Similarly, targeting GSK3β to restore Beclin-1 expression and LC3B-II conversion in neuronal models may offer a translatable strategy for neurodegenerative diseases, where impaired autophagic flux is a major pathological driver (Joshi et al., 2017; Sophia et al., 2018). The gene discussed is GSK3B; the disease is neurodegenerative disease.